Literature DB >> 2146303

Abnormal zymosan-induced neutrophil chemiluminescence as a marker of depression.

B O'Neill1, B E Leonard.   

Abstract

Preliminary studies have shown that polymorphonuclear neutrophil (PMN) activity is decreased in a state-dependent manner in patients with endogenous depression. The present study investigates this finding in a larger group of psychiatric patients and attempts to determine the identification of the factor responsible for the abnormal neutrophil function. Chemiluminescence responses of PMNs from patients with diagnoses of endogenous depression, panic disorder, anxiety, schizophrenia and alcoholism were assessed concurrently with age- and sex-matched control subjects. The reduction in PMN activity was observed in panic disorder patients as well as during depression but remained normal in schizophrenia, alcoholism and generalised anxiety. The defect in PMN function appears to be related to an abnormal factor in the serum of the patient which is corrected on clinical recovery. Aspirin-inhibited prostaglandin synthesis resulted in an enhancement of PMN activity in healthy subjects, suggesting a possible role for prostaglandins in the abnormal PMN response.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2146303     DOI: 10.1016/0165-0327(90)90104-g

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  3 in total

Review 1.  Photon emission of phagocytes in relation to stress and disease.

Authors:  E M Lilius; P Marnila
Journal:  Experientia       Date:  1992-12-01

2.  Phagocytosis and killing of Staphylococcus aureus: effects of stress and depression in children.

Authors:  J A Bartlett; M K Demetrikopoulos; S J Schleifer; S E Keller
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

Review 3.  Psychobiology of depression/distress in congestive heart failure.

Authors:  Kaki M York; Mustafa Hassan; David S Sheps
Journal:  Heart Fail Rev       Date:  2008-03-27       Impact factor: 4.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.